ENTPD1 and neoplasm: In line with previous reports, our study did not show any significant differences in the distribution of total Tregs between PB and BM [31,37], although specific subsets with enhanced suppressive functions (i.e., effector/effector memory Tregs, terminal effector Tregs, CD39+ Tregs) prevailed in the BM tumor site.